GE Healthcare showcases new cardiology technology
According to the National Cancer Policy Board, it is estimated that by the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease. That is why researchers at The Cancer Institute of New Jersey (CINJ) are taking a closer look at the specific needs of cancer
Full Post: Cancer survivor needs examined beyond specialized care
GE Healthcare continues to re-invent and re-imagine cardiology and the innovations that may help fuel the field through the future.
At the 2008 Scientific Sessions of the American Heart Association, in New Orleans this week, the company plans to showcase new products, new relationships and, above all, a new way to look at clinical practice.
Three new ultrasound devices are making a U.S. debut this week. The Vivid E9 is making the promise of true 4D heart imaging and opening the door to full cardiac studies in a completely 4D environment. Vivid q adds quantitative analysis to portable excellence, bringing even more diagnostic confidence into the equation while its intravascular ultrasound (ICE) imaging probe opens up an entirely new care area. All of these products are ready to help take users and their patients in directions they can only dream of.
Among the new releases from GE’s Diagnostic Cardiology business at AHA is EMR Gateway, an innovation that delivers electrocardiogram (ECG) results and patient demographic data to virtually any Electronic Medical Records (EMR) system. In addition, the company will announce a new electrocardiograph system in MAC 1600, Event Recording for advanced arrhythmia assessment and a new version of its ECG management system. These advancements are all designed to aid healthcare providers in efficient selection of appropriate treatment.
GE Healthcare’s Ultrasound Service team is set to announce the availability of AcoustiCare, a package including as many as four, fully covered, transesophageal ultrasound probe repairs per year. Each repair consists of genuine, upgraded OEM parts and results in a like-new, remanufactured transducer probe. GE’s Interventional Service team for Hemodynamic & EP Recording Equipment, including Mac-Lab IT, CardioLab IT ? and ComboLab IT, will unveil Proactive System Check-up & Patch Management coverage for facilities needing optimal efficiency & security. This proactive system check-up can improve network performance, prevent workflow interruption and keep the system performing at optimal levels.
Dilon Technologies, Inc., the leader in molecular breast imaging, announced today that they have formed an alliance with Terason Ultrasound to offer an expanded imaging capability when molecular breast imaging and ultrasound may be required. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage
Full Post: Dilon Technologies forms alliance with Terason Ultrasound in diagnostic imaging
European researchers have developed highly sensitive ultrasound equipment that can detect tiny quantities of reflective microbubbles engineered to stick to specific tumour cells. The technique should pick up tumours early and improve patients’ chances of survival. Most of the current diagnostic methods - biopsy analysis, biochemical tests and medical imaging - are not sufficiently sensitive.
Full Post: Sensitive ultrasound to spot early-stage cancer
The world’s first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT). Professor Alan Preece and Dr Ian Craddock from the University of Bristol have been working for a number of years to develop a
Full Post: New technology could revolutionse breast cancer screening
In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity. Their findings, published in the Oct. 29 issue of the journal Public Library of Science (PLoS) One, provide insights into how low-power ultrasound can be harnessed
Full Post: Pulsed ultrasound used to remote control brain circuits
Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the diagnosis of invasive lobular carcinoma (ILC), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. When compared to mammography, ultrasound and
Full Post: Molecular breast imaging technique shows greater sensitivity over mammography, ultrasound and MRI for difficult to diagnose breast cancer